Charlie Mann

Founder, Executive Director, CEO

Charles is a co-founder of APH, and is focussed on APH’s commercialisation and growth strategy, whilst navigating the regulatory element of the emerging hemp industry.

Charles has significant farming experience, particularly in the hemp, poppy, sheep, cattle and dairy industries.

Charles and his family maintain significant holdings in businesses that are successfully operating in the agricultural sector. Prior to establishing his own operations in the agricultural industry, Charles had extensive experience in importing, licensing, distribution and logistics within the framework of the Department of Transport and Regional Services for Vectrix Australia Pty Ltd.

James Hood

Founder, Executive Director, COO

James is a co-founder of APH, with substantial experience in production facility development and an extensive network of farmers, which has positioned APH well to produce a complete vertically integrated product line.

Prior to APH, James had roles in digital software applications and marketing.

Cameron Petricevic

Non-executive Director and Chair

Cameron has spent over 15 years in the financial industry, with roles at AXA Asia Pacific Holdings (now AMP) and Acorn Capital. Cameron has extensive investment banking experience, including valuations, mergers & acquisitions, and portfolio management. Cameron is a Director at Kentgrove Equity Partners Pty Ltd.

Cameron is a qualified Actuary (AIAA) and holds a Bachelor of Commerce (Actuarial) and a Bachelor of Engineering (Electrical) from the University of Melbourne, with First Class Honours. He is also a Graduate of the Australian Institute of Company Directors (GAICD) and Founder/Treasurer of Brimbank ToRCH, a Royal Children’s Hospital auxiliary charity.

Cameron is currently and has been a Director of several private and public companies. He has been a director of Alchemia since June 2018 and currently serves as the Chair.

Pauline Gately

Non-Executive, Independent Director

Ms. Gately has more than 20 years’ experience in international investment banking, specialising in the Asian region, where she held senior positions with CitiBank, BNP International, Merrill Lynch, and BZW Asia in the areas of research, economics and investment strategy. Ms. Gately was employed at Merrill Lynch & Co Inc., in the research division. 

Ms Gately has been a non-executive director of Ardiden Limited (ASX: ADV) since 14 August 2018. Prior to this position, Ms. Gately served as a non-executive and subsequently executive chairperson of Alliance Mineral Assets Limited (ASX: A40) from 2014 to 2018. She serves as a Director of Beaverbrook Ltd and Breast Cancer Care WA.

Ms Gately obtained an honours degree in Economics from Strathclyde University, after which she obtained a Graduate Diploma in Accounting from Glasgow University. She is a graduate and member of the Australian Institute of Company Directors.

Pauline will chair the Audit and Risk Committee and the Remuneration and Nomination Committee.